Middleman EL - Search Results

1

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH. Talbot SM, et al. Among authors: middleman el. Cancer. 2003 Jul 15;98(2):331-6. doi: 10.1002/cncr.11512. Cancer. 2003. PMID: 12872353 Free article. Clinical Trial.

2

A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.

Lynch TJ, Fenton D, Hirsh V, Bodkin D, Middleman EL, Chiappori A, Halmos B, Favis R, Liu H, Trepicchio WL, Eton O, Shepherd FA. Lynch TJ, et al. Among authors: middleman el. J Thorac Oncol. 2009 Aug;4(8):1002-9. doi: 10.1097/JTO.0b013e3181aba89f. J Thorac Oncol. 2009. PMID: 19633475 Free article. Clinical Trial.

3

A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.

Brufsky A, Hoelzer K, Beck T, Whorf R, Keaton M, Nadella P, Krill-Jackson E, Kroener J, Middleman E, Frontiera M, Paul D, Panella T, Bromund J, Zhao L, Orlando M, Tai F, Marciniak MD, Obasaju C, Hainsworth J. Brufsky A, et al. Clin Breast Cancer. 2011 Aug;11(4):211-20. doi: 10.1016/j.clbc.2011.03.019. Epub 2011 Jul 1. Clin Breast Cancer. 2011. PMID: 21723792 Clinical Trial.

4

Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin.

Middleman EL, Watanabe A, Kaizer H, Bodey GP. Middleman EL, et al. Cancer. 1972 Aug;30(2):573-9. doi: 10.1002/1097-0142(197208)30:2<573::aid-cncr2820300238>3.0.co;2-o. Cancer. 1972. PMID: 5051680 No abstract available.

5

Clinical trials with adriamycin.

Middleman E, Luce J, Frei E 3rd. Middleman E, et al. Cancer. 1971 Oct;28(4):844-50. doi: 10.1002/1097-0142(1971)28:4<844::aid-cncr2820280407>3.0.co;2-9. Cancer. 1971. PMID: 5111740 No abstract available.

6

Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.

Butts CA, Bodkin D, Middleman EL, Englund CW, Ellison D, Alam Y, Kreisman H, Graze P, Maher J, Ross HJ, Ellis PM, McNulty W, Kaplan E, Pautret V, Weber MR, Shepherd FA. Butts CA, et al. Among authors: middleman el. J Clin Oncol. 2007 Dec 20;25(36):5777-84. doi: 10.1200/JCO.2007.13.0856. J Clin Oncol. 2007. PMID: 18089875 Clinical Trial.

7

Infections in cancer patients. Results with gentamicin sulfate therapy.

Bodey GP, Middleman E, Umsawadi T, Rodriguez V. Bodey GP, et al. Cancer. 1972 Jun;29(6):1697-701. doi: 10.1002/1097-0142(197206)29:6<1697::aid-cncr2820290638>3.0.co;2-k. Cancer. 1972. PMID: 4555556 Clinical Trial. No abstract available.

8

Carbenicillin therapy for pseudomonas infections.

Bodey GP, Whitecar JP Jr, Middleman E, Rodriguez V. Bodey GP, et al. JAMA. 1971 Oct 4;218(1):62-6. JAMA. 1971. PMID: 4937796 No abstract available.

9

Intravenous gentamicin therapy for infections in patients with cancer.

Bodey GP, Middleman E, Umsawasdi T, Rodriguez V. Bodey GP, et al. J Infect Dis. 1971 Dec;124 Suppl:S174-9. doi: 10.1093/infdis/124.supplement_1.s174. J Infect Dis. 1971. PMID: 5126243 No abstract available.

10

Tubular complexes of endoplasmic reticulum in lymphoblastic lymphoma: case report.

Chu H, Foucar K, Barlogie B, Middleman E. Chu H, et al. Cancer. 1982 Apr 15;49(8):1629-35. doi: 10.1002/1097-0142(19820415)49:8<1629::aid-cncr2820490817>3.0.co;2-#. Cancer. 1982. PMID: 6978174 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters